does when it is located in its more familiar perch on the plasma membrane. Indeed, if it were located on the lumen of the ER/Golgi and acted in its usual manner, one would expect that, as the Ca 2+ stores in the Golgi or ER reached their highest concentrations, the CaR would be activated, generate IP 3 , which would bind to IP 3 (Patterson et al., 2002) . How their functions differ when complexed to CaR is unknown, but it is possible that CaR exerts additional effects via its actions on phospholipase Cγ1 and/or IP 3 R. Answers to these questions await further studies.
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Enzymes of the cytochrome P450 (CYP) superfamily serve numerous important roles in the health, damage, and function of skin (Ahmad and Mukhtar, 2004) . The CYPs are the most important among the drug-metabolizing enzymes in the skin by virtue of their crucial role in controlling the steady-state concentrations of a variety of bioactive substances (Mukhtar and Khan, 1989) . The primary role of CYP enzymes is to participate in metabolic transformation of not only endogenous substrates (fatty acids, eicosanoids, sterols, steroids, vitamin A, and vitamin D) but also xenobiotic materials (such as pollutants, cigarette smoke, and other exogenous compounds) to which human skin is either deliberately or inadvertently exposed. The xenobiotics that come into contact with the skin can be biotransformed into harmless or less harmful agents by enzymatic reactions catalyzed by a variety of metabolizing enzymes, including CYPs present in the skin (Ahmad and Mukhtar, 2004) . This ability to metabolize agents that diffuse through it is part of what constitutes the barrier function of the skin, and it leads to altered biological activities of the original compounds. This biotransformation, however, can result in either degradation or activation, the latter of which may result in skin sensitization or even carcinogenesis. In addition, because they can modulate drug bioavailability in the skin, the CYPs are important targets to be considered in drug development for skin disease. For this reason, a proper understanding of the mechanisms involved in the biotransformation of endogenous and exogenous substrates by CYP in the skin is of utmost importance.
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Human CYP cocktail provides a simplifi ed alternative method in mechanistic studies of CYP-mediated skin metabolism.
Allergic contact dermatitis is a common occupational and environmental health problem caused by chemicals that come in close contact with the skin. It has been reported that Europeans are commonly sensitized to one or more chemicals, and it is important to identify and evaluate the sensitizing potency of chemical allergens to provide precise risk assessments regarding their safe use. Once an individual has become sensitized, the allergy remains throughout life, because no restorative therapy is known. To thwart allergic contact dermatitis, exposure to the allergenic compound must be avoided. Thus, it is important to identify chemical allergens and evaluate their sensitizing potency. Most contact allergens contain electrophilic functional groups that can react with nucleophilic amino acids in proteins via polar reaction mechanisms (Roberts and Lepoittevin, 1998) . On the contrary, there is also a group of contact allergens that seems to act through nonpolar mechanisms (Rosenkranz et al., 1999) . Some of these sensitizing but protein-unreactive compounds are activated into reactive products and are referred to as prohaptens. There is a great interest in the development of methods for the prediction of contact allergenic activity. Most methods of identifying allergens do not take into account the possible activation of prohaptens to sensitizers by skin metabolism. As a consequence, consumer products undergo prolonged and expensive safety testing in an attempt to eliminate allergic contact dermatitis. To identify prohaptens, studies regarding their structure-ctivity relationships and the mechanisms of their activation must be conducted. At present the murine local lymph node assay is the method of choice for identification and potency assessment of contact allergens (Kimber et al., 1995) . The other alternative techniques include cell-based assays (Ryan et al., 2001) , chemical reactivity assays (Gerberick et al., 2004) , and in silico methods (Fedorowicz et al., 2005) . Development of a robust ex vivo or in vitro human enzyme-based assay for identification of prohaptens is required to streamline and increase the predictive efficiency of current safety test methods and, importantly, to make animal models such as the local lymph node assay unnecessary.
Alternative methods that do not take skin metabolism into account will not detect prohaptens as sensitizers. Previous study has shown that the conjugated diene (5R)-5-isopropenyl-2-methyl-1-methylene-2-cyclohexene is a prohapten, and its allergenic activity is exerted by metabolic conversion of the diene into two sensitizing epoxides: an endocyclic epoxide and an exocyclic epoxide in liver microsomes (Nilsson et al., 2005) . Bergström and co-workers (2007, this issue) used human CYP enzymes in a cocktail in ratios appropriate to the human skin. It is suggested that the metabolites generated this way would resemble those expected in the skin. The approach is creative and challenging compared with work performed on liver tissue, with its high abundance of multiple CYPs and other enzymes. In doing this the authors concentrated the skin CYP 1,000-fold in order to obtain reliable measurements of metabolite output. It is also suggested that the keratinocytes prepared from human skin might generate a microenvironment containing these metabolites. It is important to use keratinocytes and keratinocyte CYP, as they are the first cell type to encounter a potential allergy. The skin-like recombinant human CYP cocktail provides a simplified alternative method for using skin tissue preparations in mechanistic studies of CYP-mediated skin metabolism of prohaptens and offers the future possibility of designing in vitro predictive assays for assessment of allergenic activity of prohaptens. This study is a nice beginning to take our existing understanding of cutaneous metabolism to an important new level that may lead to some very practical applications in the area of contact allergy and product development.
In the follow-up studies it may also be imperative to include phase II enzymes as well, as these would tend to "deactivate" CYP metabolites to more water-soluble and nonreactive compounds. It is also important to examine an array of other potential prohaptens, others that have been well characterized. Validation will be necessary to establish that this CYP cocktail has predictive value for ingredient screening. With additional work, we may be able to establish a databank of molecular structures likely to produce reactive metabolites.
